Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability

Abstract excerpt

Prenatal exposure to the anti-seizure medication sodium valproate (VPA) is associated with an increased risk of adverse postnatal neurodevelopmental outcomes, including lowered intellectual ability, autism spectrum disorder and attention-deficit hyperactivity disorder. In this study, we aimed to clarify the molecular mechanisms underpinning the neurodevelopmental consequences of gestational VPA exposure using...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Pharmacological Effects and Toxicity Studies
• Share to Pregnancy and Medication Impact
• Share to Pregnancy and preeclampsia studies